Skip to main content
    S

    Syndax Pharmaceuticals Inc (SNDX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.20
    +0.07 (+0.77%)

    Market Cap: $850.77M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Syndax Pharmaceuticals Inc (SNDX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Syndax Pharmaceuticals (SNDX) has a latest price of $9.20 on Nov 17, 2026, 64.0% below its 52-week high of $25.59. Its price fell 44.6% over the past 12 months. The month-end price rose 15.6% over the 10 years through Oct 2026, a compound annual rate of 1.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $28.70 in Jan 2023 and its lowest $4.45 in Dec 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart SNDX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SNDX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 55.7%, and over 6 months it fell 52.5%. The month-end price fell 3.1% over the 3 years through Oct 2026, a compound annual decline of 1.0%.

    PeriodChange
    1 month-29.7%
    3 months-55.7%
    6 months-52.5%
    12 months-44.6%
    12 months, with dividends-44.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-3.1%-1.0%
    5 years-29.8%-6.8%
    10 years+15.6%+1.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 153.3%, and its weakest was 2018, when it fell 49.2%.

    YearCloseChange
    2026 through Oct 2026$13.65-35.0%
    2025$21.01+58.9%
    2024$13.22-38.8%
    2023$21.61-15.1%
    2022$25.45+16.3%
    2021$21.89-1.6%
    2020$22.24+153.3%
    2019$8.78+97.3%
    2018$4.45-49.2%
    2017$8.76+22.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 38.0% below its 50-day average of $14.83 and 53.1% below its 200-day average of $19.61.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.20
    52-week high$25.59-64.0%
    52-week low$9.06+1.5%
    50-day average$14.83-38.0%
    200-day average$19.61-53.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 64.8%.

    MeasureValue
    1-year beta0.78
    Largest fall, 1 year-63.7%
    Largest fall, 3 years-64.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About SNDX

    What is SNDX's 1-year price change?

    Syndax Pharmaceuticals's price fell 44.6% over the past 12 months. With dividends included, the 12-month total return was -44.6%.

    What is SNDX's 5-year price change?

    Syndax Pharmaceuticals's month-end price fell 29.8% over the 5 years through Oct 2026, a compound annual decline of 6.8%. These figures leave out dividends.

    What is SNDX's 52-week high and low?

    Syndax Pharmaceuticals's 52-week high is $25.59 and its 52-week low is $9.06. Its latest price of $9.20 on Nov 17, 2026 is 64.0% below the high.

    What is SNDX's beta?

    Syndax Pharmaceuticals's 1-year beta against the S&P 500 is 0.78, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 63.7%.

    Is the SNDX chart free?

    Yes. Advanced Charting for SNDX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.